Companion Animal Vaccines Market Grows at a Remarkable CAGR of 6.5% with US$4,437.0 Million by 2027 | Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva, Merck


pet vaccines market

Companion animal vaccines market is expected to grow from 2020 to 2027. The product types that make up this market are recombinant vaccines, live attenuated vaccines, DNA vaccines, conjugate vaccines, toxoid vaccines, inactivated vaccines and subunit vaccines. The types of animals are canids, equines and felines. Distribution channels include veterinary hospitals, clinics and research centers.

In order to develop a cutting-edge vaccine against infectious diseases such as rabies, Lyme disease, cancer and distemper in companion animals, vaccine manufacturers have benefited from growth opportunities thanks to technological advances, to increasing research and development in the fields of pathogenicity, immunology, and epidemiology, and the introduction of genetic engineering.

EVVIVAX, a company specializing in veterinary vector immunotherapy and vaccine development that offers new treatment options for pet cancer patients, developed Tel-eFax, a new vaccine in December 2018 that identifies telomerase , the enzyme that holds telomeres together and prevents them from getting shorter during cell division. Tel-eFax has been shown to be beneficial in three studies for the treatment of canine B-cell lymphoma, and it is currently being studied in companion animals for various tumor types.

For more business strategies, request a sample copy of this research report 🙂 @ https://www.coherentmarketinsights.com/insight/request-sample/3387

Impact

Since the outbreak of the COVID-19 virus in December 2019, the disease has spread to more than 100 countries around the world and the World Health Organization has labeled it a public health emergency. As of January 20, 2021, more than 96.2 million people worldwide were affected by the outbreak of the coronavirus disease (COVID-19), according to a report by the World Health Organization.

COVID-19 could affect the economy in three main ways: directly changing supply and demand, disrupting distribution networks, and having an economic impact on businesses and financial markets. Many countries, including China, India, Saudi Arabia, United Arab Emirates, Egypt and others, are struggling to move vaccines from place to place due to widespread lockdowns.

A COVID-19 vaccination for pets is being developed by veterinary research centers as a preventative approach. A vaccine and diagnostic kits are being developed by the Indian Veterinary Research Institute (IVRI) in collaboration with IIT-Roorkee, India to explore the dynamics of COVID-19 transmission in domestic animals and wild animals, according to a June 2020 announcement. Additionally, due to the growing demand for these vaccines, the pet vaccines markett is expected to experience considerable expansion in the near future. Demand and supply are expected to meet the needs of customers whose pet vaccination regimens have been postponed due to the pandemic after manufacturing facilities reopen.

The treatment of various diseases like cancer, allergies, and diabetes is expected to accelerate the growth of the pet vaccines market over the forecast period. Rising healthcare costs for pets are also expected to contribute to the significant growth of the pet vaccines market over the forecast period. For example, data from the American Pet Products Association (APPA) from March 2019 indicates that pet care spending rose more than 4% in 2018 to $72.5 billion from $69.5 billion. billion dollars in 2017.

Get Full Sample PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/3387

Key points to remember

The development of innovative companion animal vaccines is expected to drive research from major players and veterinary research institutes, which will drive a CAGR of 6.5% for the global companion animal vaccines market during the forecast period. For example, Indian Immunologicals Ltd. introduced the nation’s first canine Parvo nasal vaccination in December 2017. The Megavac-P-Nasal vaccination provides protection for puppies four to six weeks old. It is a live attenuated canine parvovirus vaccine administered intravenously and generated in cell culture.

The live attenuated vaccines market is expected to occupy a significant position in the market in 2020 due to the advantages of live attenuated vaccines such as minimizing the shedding of viruses that can contaminate animal products for human consumption.

The canine category is expected to take the leading market position among animal species in 2020 due to the increased occurrence of rabies in canines across the world.

Orofino Animal Health, Elanco Animal Health Incorporated, Biogénesis Bagó, Boehringer Ingelheim GmbH, HIPRA, Ceva, Zoetis Inc., Merck & Co., Inc. and Virbac are major industry players in the companion animal vaccination market.

Grab the Offer and Get Flat Rate 30% Discount on this Research Report 2022-2028 @ https://www.coherentmarketinsights.com/promo/buynow/3387

Contents

  1. Research objectives and hypotheses
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market scope
    • Description of the report
      • Market definition and scope
    • Summary
      • Market extract, by product type
      • Market extract, by type of animal
      • Market extract, by distribution channel
      • Market extract, by region
    • Consistent Opportunity Map (COM)
  3. Market dynamics, regulation and trend analysis
    • Market dynamics
      • Drivers
      • Constraints
      • Market opportunities
    • Impact analysis
    • Key developments
    • Recent product launches and approvals
    • Regulatory scenario
    • PEST analysis
    • Refund scenario
    • Mergers and Acquisitions
    • Value chain analysis
    • Epidemiology
  4. Global Companion Animal Vaccines Market – Impact of the Coronavirus (COVID-19) Pandemic
    • Economic impact
    • Research and development
    • Government measures to combat COVID-19
  5. Global Companion Animal Vaccines Market, by Product Type, 2016-2027, (USD Million)
    • Introduction
      • Market share analysis, 2020 and 2027 (%)
      • Annual Growth Analysis, 2017 – 2027
      • Industry trends
    • Live attenuated vaccine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Conjugate vaccine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Inactivated vaccine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Subunit vaccine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Toxoid vaccine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • DNA vaccine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Recombinant vaccine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
  6. Global Companion Animal Vaccines Market, by Animal Type, 2016-2027, (USD Million)
    • Introduction
      • Market share analysis, 2020 and 2027 (%)
      • Annual Growth Analysis, 2017 – 2027
      • Industry trends
    • Canine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Feline
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Equine
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Others
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
  7. Global companion animal vaccines market, by distribution channel, 2016-2027, (USD Million)
    • Introduction
      • Market share analysis, 2020 and 2027 (%)
      • Annual Growth Analysis, 2017 – 2027
      • Industry trends
    • Veterinary clinics
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Veterinary hospitals
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Veterinary Research Institute
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)
    • Others
      • Introduction
      • Market size & forecast and annual growth, 2016-2027, (USD Million)

See press release: https://www.coherentmarketinsights.com/press-release/companion-animal-vaccines-market-2751

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We are known for our actionable insights and genuine reports in various fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insight in various post-COVID-19 industries and to continuing to deliver measurable and sustainable results to our clients.

Contact us:

Mr Shah
Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Previous Report shows contamination at Easton Village Store is worse than city said
Next Walk-in Pet Wellness Clinic opens in Somerset County